WallStreetZenWallStreetZen

NASDAQ: ZYME
Zymeworks Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for ZYME

Based on 7 analysts offering 12 month price targets for Zymeworks Inc

Min Forecast
$32.00+32.73%
Avg Forecast
$43.57+80.72%
Max Forecast
$58.00+140.56%

Should I buy or sell ZYME stock?

Based on 7 analysts offering ratings for Zymeworks Inc.

Strong Buy
Strong Buy
3 analysts 42.86%
Buy
4 analysts 57.14%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although ZYME's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates ZYME as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their ZYME stock forecasts and price targets.

ZYME stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-05-08
lockedlocked$00.00+00.00%2026-03-09
lockedlocked$00.00+00.00%2026-03-06
lockedlocked$00.00+00.00%2026-03-03Find Out Why
lockedlocked$00.00+00.00%2026-03-03
Truist Securities
Bottom 13%
13
Strong BuyInitiates Coverage On$40.00+65.91%2025-12-17
Citizens
Bottom 8%
8
BuyInitiates Coverage On$32.00+32.73%2025-12-03

1 of 1

Forecast return on equity

Is ZYME forecast to generate an efficient return?

Company
22.19%
Industry
91.4%
Market
169.86%
ZYME's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is ZYME forecast to generate an efficient return on assets?

Company
7.59%
Industry
27.73%
ZYME is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

ZYME earnings per share forecast

What is ZYME's earnings per share in the next 3 years based on estimates from 15 analysts?

Avg 1 year Forecast
$1.23
Avg 2 year Forecast
$0.09
Avg 3 year Forecast
$0.38

ZYME revenue forecast

What is ZYME's revenue in the next 3 years based on estimates from 14 analysts?

Avg 1 year Forecast
$288.0M+254.36%
Avg 2 year Forecast
$214.8M+164.34%
Avg 3 year Forecast
$218.0M+168.22%
ZYME's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

ZYME revenue growth forecast

How is ZYME forecast to perform vs Biotechnology companies and vs the US market?

Company
35.47%
Industry
35.54%
Market
14.06%
ZYME's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
ZYME's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

ZYME vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ZYME$24.11$43.57+80.72%Strong Buy
ADMA$7.60$19.00+150.00%Strong Buy
VCEL$34.45$53.00+53.85%Strong Buy
ATAI$4.81$16.33+239.56%Strong Buy
NBTX$36.76$33.00-10.23%Buy
View Top Biotech Stocks

Zymeworks Stock Forecast FAQ

Is Zymeworks Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 7 Wall Street analysts covering (NASDAQ: ZYME) stock is to Strong Buy ZYME stock.

Out of 7 analysts, 3 (42.86%) are recommending ZYME as a Strong Buy, 4 (57.14%) are recommending ZYME as a Buy, 0 (0%) are recommending ZYME as a Hold, 0 (0%) are recommending ZYME as a Sell, and 0 (0%) are recommending ZYME as a Strong Sell.

If you're new to stock investing, here's how to buy Zymeworks stock.

What is ZYME's earnings growth forecast for 2026-2028?

(NASDAQ: ZYME) Zymeworks's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 16.06%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 33.47%.

Zymeworks's earnings in 2026 is -$102,656,000.On average, 15 Wall Street analysts forecast ZYME's earnings for 2026 to be $89,781,853, with the lowest ZYME earnings forecast at -$15,028,146, and the highest ZYME earnings forecast at $184,784,856. On average, 13 Wall Street analysts forecast ZYME's earnings for 2027 to be $6,499,052, with the lowest ZYME earnings forecast at -$88,737,624, and the highest ZYME earnings forecast at $232,403,194.

In 2028, ZYME is forecast to generate $27,763,368 in earnings, with the lowest earnings forecast at -$55,314,969 and the highest earnings forecast at $112,251,049.

What is ZYME's revenue growth forecast for 2026-2028?

(NASDAQ: ZYME) Zymeworks's forecast annual revenue growth rate of 35.47% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 35.54%, and while it is forecast to beat the US market's average forecast revenue growth rate of 14.06%.

Zymeworks's revenue in 2026 is $81,263,000.On average, 14 Wall Street analysts forecast ZYME's revenue for 2026 to be $21,027,720,646, with the lowest ZYME revenue forecast at $6,702,129,562, and the highest ZYME revenue forecast at $28,171,566,703. On average, 13 Wall Street analysts forecast ZYME's revenue for 2027 to be $15,686,083,733, with the lowest ZYME revenue forecast at $9,374,700,571, and the highest ZYME revenue forecast at $26,362,055,252.

In 2028, ZYME is forecast to generate $15,916,106,376 in revenue, with the lowest revenue forecast at $8,484,549,458 and the highest revenue forecast at $23,232,286,857.

What is ZYME's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: ZYME) forecast ROA is 7.59%, which is lower than the forecast US Biotechnology industry average of 27.73%.

What is ZYME's Price Target?

According to 7 Wall Street analysts that have issued a 1 year ZYME price target, the average ZYME price target is $43.57, with the highest ZYME stock price forecast at $58.00 and the lowest ZYME stock price forecast at $32.00.

On average, Wall Street analysts predict that Zymeworks's share price could reach $43.57 by May 8, 2027. The average Zymeworks stock price prediction forecasts a potential upside of 80.72% from the current ZYME share price of $24.11.

What is ZYME's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: ZYME) Zymeworks's current Earnings Per Share (EPS) is -$1.37. On average, analysts forecast that ZYME's EPS will be $1.23 for 2026, with the lowest EPS forecast at -$0.21, and the highest EPS forecast at $2.53. On average, analysts forecast that ZYME's EPS will be $0.09 for 2027, with the lowest EPS forecast at -$1.22, and the highest EPS forecast at $3.18. In 2028, ZYME's EPS is forecast to hit $0.38 (min: -$0.76, max: $1.54).

What is ZYME's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: ZYME) forecast ROE is 22.19%, which is considered strong.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.